stopped tirzepatide Lilly demands doctors stop selling copycat weight-loss drugs TrimRX What Happens When You Stop

Supplements do not target the GLP-1 and GIP receptors that regulate appetite hormones, making prescription therapy fundamentally more potent for significant, sustained weight loss

Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus and chronic weight management

Subsequently, they boost the release of growth hormone (GH) by acting on the natural release cycle of growth hormone-releasing hormone (GHRH) receptors in the pituitary gland

doi.org/10.1056/NEJMoa2307563 3Applied Clinical Trials (2026)

However, under oxidative stress conditions, Nrf2 dissociates from Keap1 and translocates to the nucleus, where it activates various antioxidant genes, including HO-1, protecting cells from oxidative damage